Cell therapy consumables market is projected to grow at a CAGR of 18% during 2021-2031.
Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrative opportunities for consumable providers having capabilities for raw material production
London
Roots Analysis has announced the addition of the “Cell Therapy Consumables Market, 2021 – 2031” report to its list of offerings.
Currently,
more than 800 IND applications have been filed for cell therapies, while close
to 10 cell-based / gene therapies are likely to receive approval in 2021 across
the world. This has prompted several drug developers to rely on third-party
service providers that claim to have the required skillset and technical
infrastructure for the production of raw materials, such as cell culture
medium, cell isolation kits and cell separation reagents, in order to produce
quality cellular therapies.
To
order this 230+ page report, which features 110+ figures and 120+ tables,
please visit this https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html
Key Market Insights
Presently, more than 60 players claim to provide cell
therapy consumable products
This segment of the industry is dominated by start-ups /
small companies (2-50 employees) and mid-sized players (51-200 employees),
which represent more than 70% of the total consumable providers. In addition, around
48% players were established before 2001, while about 25% were founded post 2010.
Currently, media products capture the highest share (73%) of
the cell therapy consumables market
Most of the cell therapy media are being developed for stem
cell therapies (72%), followed by those intended for T-cell therapies (21%). It
is worth noting that all cell therapy media are currently used for research
purposes, followed by those employed for therapeutic purposes (16%).
85+ consumable facilities dedicated to cell therapies have
been established worldwide
North America has emerged as the consumable hub for cell
therapies, featuring the presence of nearly 65% of the total consumable
facilities; this is followed by Europe (21%). Other emerging regions include (in
decreasing order of number of facilities) Japan, China, India and South
Korea.
Partnership activity in this domain has increased at a CAGR
of over 39%, between 2016 and 2021
Acquisitions and
product commercialization agreements emerged as the most popular types of
partnership models adopted by industry stakeholders (19% each), followed
by distribution agreements (16%) and manufacturing agreements (10%). Around 71%
of the total expansion projects undertaken by stakeholders were
initiated since 2018.
Over 310 cell therapy developers are likely to forge
strategic alliances with consumable providers
Around 16% of the drug developers claim to have the
required expertise to offer services for more than two unique types of cell
therapies. Notable examples include (in alphabetical order) Aspire
Health Science, Bio Elpida and The Discovery Labs Center for Breakthrough
Medicines.
Global demand for cell therapy consumables is anticipated
to reach over 31 billion liters, by 2026
The present demand of consumables required for planar
process is estimated to be over 11 billion liters, while the demand of
consumables intended for suspension process is estimated to be around 0.8
billion liters.
North America and Asia-Pacific are anticipated to capture
over 65% of the market share, by 2031
The current market is driven by sales of media products designed
for cell therapies (close to 80%); this trend is unlikely to change in the
foreseen future. It is worth mentioning that the consumables market for cell
therapies in the Europe is anticipated to grow at a relatively faster pace (22.7%),
followed by the market in Asia-Pacific (20.5%).
To request a sample copy / brochure of this
report, please visit this
https://www.rootsanalysis.com/reports/cell-therapy-consumables-market/request-sample.html
Key
Questions Answered
§
Who are the key players engaged in offering consumables for
cell therapies?
§
Which regions have emerged as key hubs in terms of cell
therapy consumable related capabilities?
§
Which are the most popular media components used for cell
therapy consumables?
§
What kind of partnership models are most commonly adopted
by stakeholders engaged in this industry?
§
How is the recent COVID-19 pandemic likely to impact the
consumables market for cell therapies?
§
What are the key challenges associated with the production
of cell therapy consumables?
§
What is the current, global demand (kits, media and
reagents) for cell therapy consumables in the manufacturing process?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
§
What are the anticipated future trends related to
consumables market for cell therapies?
The
financial opportunity within the cell therapy consumables market has been analyzed
across the following segments:
§ Type
of Consumable
§ Kits
§ Media
§ Reagents
§ Type
of Cell Therapy
§ Dendritic
Cell Therapy
§ NK Cell
Therapy
§ Stem
Cell Therapy
§ T-Cell
Therapy
§ Scale
of Operation
§ Clinical
§ Commercial
§ Type
of End-User
§ Industry
§ Non-Industry
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the World
The report includes profiles of key players (listed
below) each profile features an overview of the company, details related to
its financials (if available), product portfolios, recent developments
and an informed future outlook.
§
Miltenyi Biotec
§
STEMCELL technologies
§
Bio-Techne
§
Irvine Scientific
§
Thermo Fisher Scientific
§
Sartorius
§
BD Biosciences
§
Lonza
§
CellGenix
§
Corning
For
additional details, please visit
https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.htmlor email
sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Biospecimen Contract
Research Services Market: Industry Trends and Global Forecasts, 2021-2030
2.
Pharmaceutical Contract
Manufacturing Market
(3rd Edition): Industry Trends and Global Forecasts, 2021-2030
3.
Cell Therapy
Manufacturing Market (4th Edition): Industry Trends and Global
Forecasts, 2021-2030
Contact:
Ben
Johnson
+1
(415) 800 3415
+44
(122) 391 1091
Comments
Post a Comment